Resilience Announces Joint Venture with Lifera in Saudi Arabia
The joint venture with Lifera would build an advanced large-scale, commercial drug product manufacturing facility in Riyadh, Saudi Arabia Resilience...
NEWS
Read on
Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity
Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership With Leading Pharmaceutical Company
SAN DIEGO--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to...
Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates
The facility expands Resilience’s global footprint and represents the first GMP biopharma facility in the region based in the UAE
Resilience To Establish A Biomanufacturing Partnership With AstraZeneca And Purchase AstraZeneca’s Manufacturing Site In West Chester, Ohio
Long-term partnership to be established between Resilience and AstraZeneca for the biomanufacturing of established and emerging modalities. West...
National Resilience Honored By Goldman Sachs For Entrepreneurship
Rahul Singhvi, CEO, Recognized Among the Most Exceptional Entrepreneurs at 2022 Builders and Innovators Summit
